Etomidate versus propofol sedation for complex upper endoscopic procedures: a prospective double-blinded randomized controlled trial Mi Gang Kim, MD, Se Woo Park, MD, Jae Hyun Kim, MD, Jin Lee, MD, PhD, Sea Hyub Kae, MD, PhD, Hyun Joo Jang, MD, Dong Hee Koh, MD, PhD, Min Ho Choi, MD Gastrointestinal Endoscopy Volume 86, Issue 3, Pages 452-461 (September 2017) DOI: 10.1016/j.gie.2017.02.033 Copyright © 2017 American Society for Gastrointestinal Endoscopy Terms and Conditions
Figure 1 Flow chart of patients throughout the randomized trial. SBP, systolic blood pressure; SaO2, arterial oxygen saturation. Gastrointestinal Endoscopy 2017 86, 452-461DOI: (10.1016/j.gie.2017.02.033) Copyright © 2017 American Society for Gastrointestinal Endoscopy Terms and Conditions
Figure 2 Time course of changes in heart rate, systolic blood pressure, and oxygen saturation. A, Mean values of heart rate (beats/minute). B, Systolic blood pressure (mm Hg). C, Mean arterial pressure (mm Hg). D, Hemoglobin oxygen saturation (as a percentage), determined at different stages of the study including baseline (at least 15 minutes before the initial drug administration), 5 and 10 minutes after initiating sedation during EUS, full awake time, and at discharge from the endoscopy unit. SBP, systolic blood pressure; HR, heart rate; ET, etomidate; PP, propofol; MAP, mean arterial pressure; SaO2, arterial oxygen saturation; SpO2, pulse oximetry. Vertical lines represent standard deviations. P value after correction by the Bonferroni method. Gastrointestinal Endoscopy 2017 86, 452-461DOI: (10.1016/j.gie.2017.02.033) Copyright © 2017 American Society for Gastrointestinal Endoscopy Terms and Conditions